Therapeutic potential of targeting haploinsufficient genes in cancer.

doi:10.1002/pbc.22019

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Therapeutic potential of targeting haploinsufficient genes in cancer.

Pediatric blood & cancer - 1 Aug 2009

Cheung Kevin J, Ebert Benjamin L

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Transformation, Neoplastic
Share to Genes, Tumor Suppressor
Share to Genetic Predisposition to Disease
Share to Loss of Heterozygosity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasms

Source

Open in PubMed

Identifiers

PMID: 19343773
DOI: 10.1002/pbc.22019

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic potential of targeting haploinsufficient genes in cancer.PMID 19343773Read ↗

Advancements in Cancer TreatmentsSemantic proximity Read ↗

Tumor suppressor genes: prospects for cancer therapies.Semantic proximity Read ↗

Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way.Semantic proximity Read ↗

A blueprint for advancing genetics-based cancer therapy.Semantic proximity Read ↗

Tumour suppressor genes in disease and therapySemantic proximity Read ↗

Gene Therapy Progress and Prospects: cancer gene therapy using tumour suppressor genesSemantic proximity Read ↗

Will therapies that target tumour suppressor genes be useful in cancer treatment?Semantic proximity Read ↗

Clinical applications of genetic technologies to cancer care.Semantic proximity Read ↗

Strategies for therapeutic targeting of the p53 pathway in cancer.Semantic proximity Read ↗

Specific genetic defects as targets for selective therapies. Commentary.Semantic proximity Read ↗

Tumor suppressor genes.Semantic proximity Read ↗

Recent developments in cancer therapy and why we need a human cancer genome project.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.